Robert Cresci - CREMECOMTRSBI Independent Director
WY52 Stock | EUR 0.20 0.01 5.26% |
Insider
Robert Cresci is Independent Director of CREMECOMTRSBI DL 001 since 2014.
Age | 75 |
Tenure | 10 years |
Phone | 972-349-3200 |
Web | http://www.cimcommercial.com |
CREMECOMTRSBI Management Efficiency
The company has return on total asset (ROA) of 0.0151 % which means that it generated a profit of $0.0151 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.014 %, meaning that it generated $0.014 on every $100 dollars invested by stockholders. CREMECOMTRSBI's management efficiency ratios could be used to measure how well CREMECOMTRSBI manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
Dag Sigurd | SIVERS SEMICONDUCTORS AB | 73 | |
Olivia Snyder | Office Properties Income | N/A | |
Michael Shanley | Reliance Steel Aluminum | 65 | |
Hilde Nordh | Norsk Hydro ASA | 54 | |
Matthew Brown | Office Properties Income | 41 | |
Arvid Moss | Norsk Hydro ASA | 65 | |
FCA FCA | Superior Plus Corp | 68 | |
Christopher Bilotto | Office Properties Income | 45 | |
John Thuestad | Norsk Hydro ASA | 63 | |
Hilde Aasheim | Norsk Hydro ASA | 65 | |
Kevin Barry | Office Properties Income | N/A | |
Sven Pettersson | SIVERS SEMICONDUCTORS AB | 60 | |
Eivind Kallevik | Norsk Hydro ASA | 56 | |
AnneLene Midseim | Norsk Hydro ASA | 55 | |
Jeffrey Durham | Reliance Steel Aluminum | 60 | |
Ingrid Engstrom | SIVERS SEMICONDUCTORS AB | 59 | |
Jennifer Clark | Office Properties Income | 62 | |
Patric Erlandsson | SIVERS SEMICONDUCTORS AB | 51 | |
Bjorn Norrbom | SIVERS SEMICONDUCTORS AB | 72 | |
Stephen Koch | Reliance Steel Aluminum | 56 | |
Trond Christophersen | Norsk Hydro ASA | 51 |
Management Performance
Return On Equity | 0.014 | |||
Return On Asset | 0.0151 |
CREMECOMTRSBI DL 001 Leadership Team
Elected by the shareholders, the CREMECOMTRSBI's board of directors comprises two types of representatives: CREMECOMTRSBI inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CREMECOMTRSBI. The board's role is to monitor CREMECOMTRSBI's management team and ensure that shareholders' interests are well served. CREMECOMTRSBI's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CREMECOMTRSBI's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jan Salit, President Secretary | ||
Frank Golay, Independent Director | ||
Avi Shemesh, Director | ||
Avraham Shemesh, Director | ||
David Thompson, Chief Executive Officer | ||
Robert Cresci, Independent Director | ||
Kelly Eppich, Independent Director | ||
Douglas Bech, Independent Director | ||
Richard Ressler, Chairman of the Board | ||
Shaul Kuba, Director | ||
Nathan DeBacker, Chief Financial Officer |
CREMECOMTRSBI Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CREMECOMTRSBI a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.014 | |||
Return On Asset | 0.0151 | |||
Profit Margin | 0.06 % | |||
Operating Margin | 0.16 % | |||
Shares Outstanding | 22.74 M | |||
Shares Owned By Insiders | 13.49 % | |||
Shares Owned By Institutions | 59.07 % | |||
Price To Earning | 4.83 X | |||
Revenue | 101.34 M | |||
Gross Profit | 42.62 M |
Currently Active Assets on Macroaxis
Other Information on Investing in CREMECOMTRSBI Stock
CREMECOMTRSBI financial ratios help investors to determine whether CREMECOMTRSBI Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CREMECOMTRSBI with respect to the benefits of owning CREMECOMTRSBI security.